Accessibility Menu
Invo Fertility logo

Invo Fertility(NASDAQ) INVO

Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2024)-100%
5 Year-100%
1 Year-97%
1 Month+10%
N/A
Invo Fertility last closing stock price
MetricPriceDate
Last closeUSD 1.032026-08-31
Invo Fertility stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 1.032026-08-24
1 month+9.95%USD 0.942026-07-31
3 month-32.24%USD 1.522026-06-02
Year to date-72.63%USD 3.762025-12-31
1 year-97.32%USD 38.402025-08-29
3 year-99.95%USD 2,160.002023-09-01
5 year-100%USD 112,896.002021-09-01
Since inception-99.93%USD 1,468.802024-10-15

Invo Fertility Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$2.18B

Net Income (TTM)

$883.27M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

Nov 11, 2024

INVO News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Invo Fertility

NAYA Biosciences, Inc. is a biotechnology company focused on developing innovative medical treatments. The company leverages cutting-edge research and technology to address diseases that have been challenging to treat effectively. Its strategic collaborations with leading research institutions support the rapid progression of its drug discovery and development pipeline. NAYA’s experienced leadership team plays a crucial role in navigating complex regulatory environments and driving growth through internal research and strategic acquisitions.

Products and Services

Unique platform technology for drug development

Collaborations with top-tier research institutions for drug discovery and development

Focus on previously untreatable diseases

What Makes NAYA Biosciences, Inc. Special

NAYA Biosciences stands out due to its proprietary platform technology, which allows for the development of treatments targeting diseases that have been difficult to address with traditional methods. These advancements are facilitated by strategic partnerships with esteemed research institutions, enhancing the company’s research capabilities and clinical trial processes. Experienced leadership further ensures the execution of its strategic vision effectively.

Five Things You Need to Know

Focus on developing treatments for previously challenging-to-treat diseases.

Proprietary platform technology underpins key product developments.

Strong partnerships with top research institutions bolster its innovation pipeline.

Led by a leadership team with proven expertise in regulatory and development processes.

Growth through internal R&D and strategic acquisitions for market expansion.

AI Generated • Apr 16, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

42

CEO

Steven M. Shum

Website

www.invofertility.com

Headquarters

Sarasota, FL 34240, US

INVO Financials

Key Financial Metrics (TTM)

Gross Margin

33.34%

Operating Margin

-78.72%

Net Income Margin

-70.18%

Return on Equity

-47.41%

Return on Capital

-66.74%

Return on Assets

-20.46%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$824.97M

Operating Income

-$1.29B

EBITDA

$909.31M

Operating Cash Flow

-$5.37B

Capital Expenditure

-$104.83K

Free Cash Flow

-$5.37B

Cash & ST Invst.

$3.73B

Total Debt

$4.54B

Invo Fertility Performance Analysis

Invo Fertility annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 822,196-80.2%
20232023-12-31USD 3,020,575267.4%
20242024-12-31USD 6,532,000116.3%
20252025-12-31USD 6,841,2504.7%
Invo Fertility sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-06-3016.5%
Q32024-09-30-22.0%
Q42025-12-31N/A
Q22026-06-30N/A
Invo Fertility annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -25,877.6643.6%
20232023-12-31USD -8,084.16-68.8%
20242024-12-31USD -3,178.43-60.7%
20252025-12-31USD -66.11-97.9%
Invo Fertility sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-06-30-47.6%
Q32024-09-3032.3%
Q42025-12-31N/A
Q22026-06-30N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$2.18B

+157343.7%

Gross Profit

$822.82M

+166124.9%

Gross Margin

37.82%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

25

N/A

Net Income

$888.74M

+44653.2%

EBITDA

$913.24M

+55511.5%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$3.73B

+785576.4%

Total Debt

$4.54B

+71109.4%

Accounts Receivable

$257.73M

+145601.8%

Inventory

$251.29M

+94209.0%

Long Term Debt

$2.39B

+54764.4%

Short Term Debt

$2.16B

+106175.1%

Return on Assets

-20.46%

N/A

Return on Invested Capital

-30.69%

N/A

Free Cash Flow

-$3.02B

-381916.8%

Operating Cash Flow

-$3.02B

-421980.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
IDRAIdera Pharmaceuticals, Inc.
$0.43-23.04%
ONCOOnconetix, Inc.
$0.65+3.35%
HINDVyome Holdings, Inc.
$2.18+0.92%
LSTALisata Therapeutics, Inc.
$1.60+7.05%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$218.54-0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.36-0.06%
INTCIntel
$88.79-0.01%
NUNu Holdings
$14.49-0.00%

Questions About INVO

What is the current price of Invo Fertility?

Invo Fertility is trading at N/A per share.

What is the 52-week range for Invo Fertility?

Over the past 52 weeks, Invo Fertility has traded between N/A and N/A.

How much debt does Invo Fertility have?

As of the most recent reporting period, Invo Fertility reported total debt of $3.92M.

How much cash does Invo Fertility have on hand?

Invo Fertility reported $3.73M in cash and cash equivalents in its most recent financial results.

What is Invo Fertility’s dividend yield?

Invo Fertility does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services